Address
Email address
Phone number
Website
https://www.novavita.eeEsilehekülg - Nova Vita KlinikNova Vita Kliinikul on 25 aastane kogemus viljatusravis, personaalne lähenemine ja stabiilselt kõrged tulemused.
Name
Aktsiaselts Nova Vita Kliinik
Registry code
10285009
VAT number
EE100770434
Type
AS - Joint Stock Company
Status
Registered
Foundation date
14.10.1997 (27)
Financial year
01.01-31.12
Capital
1 991 832.00 €
Activity
86221 - Provision of specialised medical treatment
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| ESO International AS 12713863 | 33% - 651 726.00 EUR | - | - | Shareholder |
| Ari Pekka Kalevi Sillanaukee 07.09.1964 (60) | - | Board member | Indirect ownership |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Celvia CC AS 11673707 | - | - | - | Founder |
| 2019 11.03.2020 | 2020 12.03.2021 | 2021 10.05.2022 | 2022 01.04.2023 | |
|---|---|---|---|---|
| Total Revenue | 1 235 144 € | 1 620 894 € | 1 879 080 € | 1 781 591 € |
| Net profit (loss) for the period | 451 591 € | 657 358 € | 346 400 € | 789 600 € |
| Profit Margin | 37% | 41% | 18% | 44% |
| Current Assets | 273 488 € | 805 673 € | 595 878 € | 1 241 277 € |
| Fixed Assets | 3 880 322 € | 3 826 304 € | 3 791 649 € | 3 768 176 € |
| Total Assets | 4 153 810 € | 4 631 977 € | 4 387 527 € | 5 009 453 € |
| Current Liabilities | 220 457 € | 468 614 € | 403 909 € | 1 345 794 € |
| Non Current Liabilities | 611 554 € | 584 207 € | 558 061 € | 448 503 € |
| Total Liabilities | 832 011 € | 1 052 821 € | 961 970 € | 1 794 297 € |
| Share Capital | 1 991 832 € | 1 991 832 € | 1 991 832 € | 1 991 832 € |
| Equity | 3 321 799 € | 3 579 156 € | 3 425 557 € | 3 215 156 € |
| Employees | 12 | 13 | 13 | 16 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 42 650.26 € | 96 152.53 € | 92 967.83 € | 17 |
| 2023 Q4 | 48 988.08 € | 91 018.03 € | 85 742.35 € | 18 |
| 2023 Q3 | 48 603.3 € | 91 348.59 € | 86 499.39 € | 19 |
| 2023 Q2 | 50 524.61 € | 93 230.29 € | 88 681.72 € | 21 |
| 2023 Q1 | 76 466.75 € | 115 135.61 € | 95 506.23 € | 24 |
| 2022 Q4 | 62 207.18 € | 87 223.37 € | 82 943.25 € | 24 |
| 2022 Q3 | 51 869.01 € | 88 882.06 € | 87 136.25 € | 23 |
| 2022 Q2 | 73 746.08 € | 79 761.85 € | 77 496.61 € | 23 |
| 2022 Q1 | 67 430.05 € | 88 977.5 € | 85 654.15 € | 21 |
| 2021 Q4 | 64 453.17 € | 79 233.33 € | 77 918.49 € | 21 |
| 2021 Q3 | 69 192.34 € | 77 655.91 € | 75 714.27 € | 21 |
| 2021 Q2 | 136 131.65 € | 73 946.21 € | 73 369.03 € | 22 |
| 2021 Q1 | 138 960.81 € | 78 115.59 € | 79 345.05 € | 21 |
| 2020 Q4 | 117 418.14 € | 78 813.82 € | 72 652.44 € | 20 |
| 2020 Q3 | 36 071.48 € | 66 573.94 € | 62 876.4 € | 20 |
| 2020 Q2 | 23 137.77 € | 18 191.85 € | 15 798.83 € | 19 |
| 2020 Q1 | 70 607.02 € | 72 406.33 € | 60 975.54 € | 19 |
